Pharma Journalist 8962 posts 0 comments

15th November 2018, Kohinoor Continental Hotel, Mumbai, India Virtue Insight is glad to announce 17th Pharmacovigilance 2018 to be held on 15th November 2018 in Mumbai, India. It…
Read More...

Genentech announced that the U.S. Food and Drug Administration (FDA) has approved 75 mg/0.5 mL and 150 mg/1 mL single-dose prefilled syringes (PFS) for Xolair (omalizumab) as an…
Read More...

Innovent Biologics announced that its IND application for IBI-188, a fully human anti-CD47 monoclonal antibody (mAb) drug candidate, has been approved by the US Food & Drug…
Read More...

Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose vaccine products, announces it has entered a Cooperative Research and Development Agreement…
Read More...

Dova Pharmaceutical and Salix Pharmaceuticals announced that they have entered into an exclusive agreement to co-promote Dova’s DOPTELET (avatrombopag) in the United States (U.S.). The…
Read More...

SMi Reports: An exclusive interview with Anita Burrell, Founder & CEO at Anita Burrell Consulting and speaker at this year’s 5th annual Biosimilars USA conference, is now available…
Read More...

Selexis SA and Hoba Therapeutics announced that they have entered into an agreement to advance the development of Hoba’s clinical candidate HB-086 (rhMeteorin) for the treatment of…
Read More...

Alexion Pharmaceuticals and Syntimmune announced that they have entered into a definitive agreement for Alexion to acquire Syntimmune, a clinical-stage biotechnology company developing…
Read More...

SMi Group announces the 10th Annual RNA Therapeutics Conference in London on February 20th - 21st 2019. Undoubtedly, the field of RNA therapeutics is currently undergoing a major…
Read More...

SMi is excited to present the return of their 11th annual Social Media in the Pharmaceutical Industry conference to London, UK on the 21st - 22nd January 2019! This year looks at…
Read More...